IronBridge Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

IronBridge Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-6,059	Closed	-$213K	–	184
2015 Q4	$213K	Sell	6,059 -343,485	-98%	-$9.2M	0.01%	178
2015 Q3	$7.4M	Sell	349,544 -7,202	-2%	-$186K	0.29%	99
2015 Q2	$9.91M	Sell	356,746 -17,370	-5%	-$490K	0.3%	86
2015 Q1	$11.4M	Sell	374,116 -66,294	-15%	-$2.11M	0.33%	75
2014 Q4	$14.1M	Sell	440,410 -13,675	-3%	-$445K	0.39%	77
2014 Q3	$12.9M	Sell	454,085 -11,655	-3%	-$325K	0.34%	76
2014 Q2	$12.8M	Sell	465,740 -113,700	-20%	-$3.03M	0.31%	90
2014 Q1	$15.3M	Buy	579,440 +112,383	+24%	+$3.22M	0.33%	94
2013 Q4	$13.7M	Sell	467,057 -12,844	-3%	-$408K	0.29%	106
2013 Q3	$14.7M	Sell	479,901 -98,620	-17%	-$3.3M	0.31%	98
2013 Q2	$18.3M	Buy	+578,521	New	+$19M	0.36%	94

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IronBridge Capital Management's GHDX Position: Q1 2016 in Review

IronBridge Capital Management sold out of Genomic Health, Inc. (GHDX) in Q1 2016, closing a stake of 6,059 shares — an estimated $213K sold.

IronBridge Capital Management first reported a position in GHDX in Q2 2013 and held it in 11 quarters. The position peaked at $18.3M in Q2 2013. 127 funds tracked by Wall St. Rank hold GHDX as of Q1 2016.

IronBridge Capital Management reported no remaining Genomic Health, Inc. position as of Q1 2016 after selling out during the quarter.
IronBridge Capital Management sold 6,059 Genomic Health, Inc. shares in Q1 2016, an estimated $213K.
IronBridge Capital Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 11 quarters.
IronBridge Capital Management's Genomic Health, Inc. position peaked at $18.3M in Q2 2013.
127 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2016.

Based on IronBridge Capital Management's 13F filing for Q1 2016, filed 11 May 2016.